ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0414

Clinical Characteristics of an Internet-Based Cohort of Participants with a Self-Reported Diagnosis of Cryoglobulinemic Vasculitis or IgA Vasculitis

Jason Springer1, Tanaz Kermani2, Dianne Shaw3, Kalen Young4, Cristina Burroughs5 and Peter Merkel6, 1University of Kansas Medical Center, Overland Park, KS, 2David Geffen School of Medicine / University of California, Los Angeles, CA, 3Vasculitis Foundation, North Carolina, 4Vasculitis Foundation, Kansas City, 5University of South Florida, Tampa, 6University of Pennsylvania, Philadelphia, PA

Meeting: ACR Convergence 2020

Keywords: American College of Rheumatology Criteria, Cryogloblulinemic Vasculitis, Miscellaneous Rheumatic and Inflammatory Diseases, Vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Cyroglobulinemic vasculitis (CV) and IgA vasculitis are forms of small-vessel vasculitis characterized by immune complex deposition. The purpose of this study was to a) describe the characteristics of an international internet-based cohort of patients with a self-reported diagnosis of CV or IgA vasculitis and b) determine the extent to which these diagnoses agreed with established definitions of disease or classification criteria.

Methods: Participants with self-reported diagnoses of CV or IgA vasculitis were included in a prospective, internet-based, longitudinal registry from November 2014 to May 2020. All information was self-reported including diagnosis, symptoms at onset, and diagnostic testing.

Results: CV: 117 participants reported a diagnosis of CV (79% female). The racial/ethnic distribution was: 86% Caucasian/White, 3% Asian, 3% Hispanic/Latino and 2% African American/Black. Mean age at diagnosis was 48.7 ± 2.6 years. 22% had a history of hepatitis C and 13% of hematologic malignancy. 96% reported positive serum cryoglobulins. Common clinical manifestations included: purpura (94%), peripheral nerve involvement (93%), joint involvement (91%), and kidney involvement (27%). The establishment of the diagnosis was by laboratory testing (84%), symptoms (60%), and biopsy (37%). 108 participants (92%) met the Chapel Hill Consensus Conference (CHCC) definition.

IgA vasculitis: 103 participants reported a diagnosis of IgA vasculitis (75% female). The racial/ethnic distribution was: 88% Caucasian/White, 5% Asian, 5% Hispanic/Latino, 2% American Indian/Alaska Native, and 1% African American/Black. Mean age at diagnosis was 42.7 ± 3.2 years, with 77 (75%) developing symptoms in adulthood (≥18 years); there were few differences in clinical manifestations based on age of presentation (Table 1). 52% reported onset after an upper respiratory infection. Common clinical manifestations included: purpura (99%), joint involvement (93%), gastrointestinal pain/bleeding (70%), and kidney involvement (66%). Patients reported their diagnosis was established by biopsy results (68%), symptoms (62%), and serum laboratory testing (52%). 96 participants (93%) met the 1990 American College of Rheumatology criteria while 70 (68%) met the CHCC definition.

Conclusion: Self-reported clinical manifestations of CV and IgA vasculitis are similar to cohorts utilizing the traditional center-based approach. In addition, most patients with these diseases met established criteria or definitions for their disease. The diagnosis of CV appears to be more commonly reliant on laboratory testing as opposed to IgA vasculitis in which the diagnosis is more heavily based on biopsy results. Patients with adult-onset IgA vasculitis were more likely to develop peripheral neuropathy and thrombocytopenia. Patient-derived data from online registries is a feasible option for the conduct of future clinical trials in these rare and understudied diseases.


Disclosure: J. Springer, InflaRx, 2; T. Kermani, None; D. Shaw, None; K. Young, None; C. Burroughs, None; P. Merkel, AbbVie, 5, Biogen, 5, Celgene, 2, 5, ChemoCentryx, 2, 5, CSL Behring, 5, Forbius, 2, 5, Genentech/Roche, 2, 5, Genzyme/Sanofi, 2, 5, GlaxoSmithKline, 2, 5, InflaRx, 2, 5, Insmed, 5, Jannsen, 5, Kiniksa, 5, Magenta, 5, Novartis, 5, Pfizer, 5, Sparrow, 5, Talaris, 5, AstraZeneca, 2, 5, Boeringher-Ingelheim, 2, 5, Bristol-Myers Squibb, 2, 5, UpToDate, 7.

To cite this abstract in AMA style:

Springer J, Kermani T, Shaw D, Young K, Burroughs C, Merkel P. Clinical Characteristics of an Internet-Based Cohort of Participants with a Self-Reported Diagnosis of Cryoglobulinemic Vasculitis or IgA Vasculitis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/clinical-characteristics-of-an-internet-based-cohort-of-participants-with-a-self-reported-diagnosis-of-cryoglobulinemic-vasculitis-or-iga-vasculitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-of-an-internet-based-cohort-of-participants-with-a-self-reported-diagnosis-of-cryoglobulinemic-vasculitis-or-iga-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology